Vyvanse 50 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FDA7W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,599
Award facts
- Contract value 100% obligated
- $13,599.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Vyvanse 50 mg capsules (100 count) with a contract value of $13,599.33 and a completion date of January 22, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio under the DLA Troop Support Medical contract encompasses a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Vyvanse, a prescription medication used in attention and focus treatment, demonstrates the company's role in supplying essential pharmaceutical commodities to support military healthcare operations and readiness requirements.
Quick answers
Who was awarded contract SPE2DR26FDA7W?
SPE2DR26FDA7W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FDA7W worth?
The government has obligated $13,599 on SPE2DR26FDA7W.
Is contract SPE2DR26FDA7W an order under another contract?
Yes. SPE2DR26FDA7W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA7W competed?
The extent of competition for SPE2DR26FDA7W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award